Origami Therapeutics
PrivateLast Round
Crowdfunding
Nov 14, 2023
Total Funding Raised
$6.62M
Company Overview
Origami Therapeutics is a biopharmaceutical company that develops disease-modifying treatments for neurodegenerative disorders using protein degraders and small molecule correctors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Origami Therapeutics Comparables
Compare Origami Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Plexium | 89% | |
| TRIMTECH Therapeutics | 85% | |
| Prazer Therapeutics | 83% |
Origami Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Nov 14, 2023 | ||||
| Grant | Sep 1, 2022 | ||||
| Seed | Apr 1, 2022 |
Origami Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Catalytic Impact Foundation | Seed |
| Y Combinator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 30, 2026
Partnered with Ipsen to develop a protein degrader program for a rare neurodegenerative disorder.
- Jan 30, 2026
Partnered with Ipsen to develop a small-molecule protein degrader program.
Recent news
Latest coverage and updates
- is_developingJun 27, 2026
Origami Therapeutics, Inc. is developing protein degraders and correctors for CNS conditions generation on Jun 27th '26.
Origami Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Origami Therapeutics's valuation, stock price, and market status.
Is Origami Therapeutics a public or private company?
Origami Therapeutics is a private company.
What is the current stock price of Origami Therapeutics?
Origami Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Origami Therapeutics worth (valuation)?
Valuation information for Origami Therapeutics is not publicly available.
Can I buy Origami Therapeutics stock?
Origami Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Origami Therapeutics's last funding round?
Origami Therapeutics's most recent funding round was Grant on September 1, 2022.
Who are the main investors in Origami Therapeutics?
Key investors in Origami Therapeutics include Y Combinator.
Will Origami Therapeutics IPO soon?
No public IPO plans have been announced for Origami Therapeutics.
How can I track Origami Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Origami Therapeutics's secondary market activity and sign up for updates.